Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D1.422 - A service review of the complex COVID-19 vaccination service
D1.425 - Familial Cold Autoinflammatory Syndrome Post COVID-19 Vaccine: A Case Report
D1.423 - Listening to Urticaria Patients Through Social Media: Analyzing the Impact of the COVID-19 Pandemic
D1.424 - Clinical-epidemiological profile of patients with Post-Covid syndrome followed at a medical school outpatient clinic
D1.426 - Cellular immunity profile in patients with urolithiasis in the presence of post-Covid syndrome
D2.167 - Effect of Metformin on allergen specific immunotherapy
D2.169 - Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children
D2.174 - Patient survey to determine the minimal clinically important difference for a combined symptom and medication score in grass AIT
D2.179 - Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study
D2.168 - Systemic reactions to subcutaneous immunotherapy in children
D2.170 - The placebo effect leads to significantly lower values regarding allergic symptoms and medication use in birch-pollen allergic patients during the birch pollen season
D2.171 - The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment
D2.172 - Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
D2.173 - Subcutaneous allergen-specific immunotherapies for inhalation allergens induce higher levels of therapy specific IgG4 antibodies than sublingual therapies: a retrospective data analysis
D2.175 - TAPAS – non-inferiority of clinical effectiveness in children compared to adults: interim results of a long-term NIS
D2.176 - Improved quality of life after PQ Grass in comparison to SLIT products in grass allergic patients
D2.177 - The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis
D2.178 - Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis
D2.180 - Immunological evaluation of cat allergic individuals living with or without a cat
D3.290 - Manifestations of allergic skin lesions in the early childhood and adult population: Epidemiological manifestations of diseases
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download